Obesity and leptin in breast cancer angiogenesis.
Saved in:
| Title: | Obesity and leptin in breast cancer angiogenesis. |
|---|---|
| Authors: | Lagarde CB; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Thapa K; Department of Cell and Molecular Biology, Tulane University School of Science and Engineering, New Orleans, LA, United States., Cullen NM; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Hawes ML; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Salim K; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Benz MC; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Dietrich SR; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States.; United States Department of Agriculture Southern Regional Research Center, New Orleans, LA, United States., Burow BE; Department of Cell and Molecular Biology, Tulane University School of Science and Engineering, New Orleans, LA, United States., Bunnell BA; Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, United States., Martin EC; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Collins-Burow BM; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Lynch RM; Department of Physiology, College of Medicine, University of Arizona, Tucson, AZ, United States., Hoang VT; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States., Burow ME; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane University Cancer Center, New Orleans, LA, United States.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, United States.; Department of Surgery, Tulane University School of Medicine, New Orleans, LA, United States., Fang JS; Department of Cell and Molecular Biology, Tulane University School of Science and Engineering, New Orleans, LA, United States.; Department of Physiology, Tulane University School of Medicine, New Orleans, LA, United States. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Oct 08; Vol. 15, pp. 1465727. Date of Electronic Publication: 2024 Oct 08 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
